Ultrasoundguided modified superior inguinal ligament iliac fascia block combined with sciatic nerve block combined with general anesthesia in total hip arthroplasty

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100050375

Enrollment

Unknown

Registered

2021-08-26

Start date

2021-10-01

Completion date

Unknown

Last updated

2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Joint replacement

Interventions

Experimental group A:Improved superior inguinal ligament iliac fascia block and sciatic nerve block under ultrasound group

Experimental group B:Improved superior inguinal ligament iliac fascia block group under ultrasound

Experimental group C:Sciatic nerve block group under ultrasound

Control group:Administer medication based on experience and vital signs

Eligibility

Sex/Gender

All

Age

40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis was rated I-III by The American Society of Anesthesiologists (ASA); 2. Unilateral total hip arthroplasty at an elective time; 3. 40-75 years old; 4. Body Mass Index (BMI) 18-30 kg /m^2; 5. Patients who are willing to accept sciatic improved superior iliac fascia block, sciatic nerve block, femoral nerve block, periarticular infiltration analgesia.

Exclusion criteria

Exclusion criteria: 1. Ppatients with multiple chronic diseases who cannot tolerate surgery and anesthesia; 2. Contraindications (local infection, sepsis, original nerve abnormalities of lower limbs); 3. Severe heart, liver and renal insufficiency; 4. local anaesthetic allergy; 5. Patients with extrarticular pain; 6. Long history of analgesia, sedative drug treatment and drug abuse; 7. Use of anticoagulants or coagulation disorders; 8. Neuromuscular disease/injury on the affected side; 9. Hip revision surgeon.

Design outcomes

Primary

Measure	Time frame
Oxygen saturation;Heart rate;Mean arterial pressure;Visual Analogue Scale/Score (VAS);Interleukin 1;Interleukin 6;Tumor necrosis factor;C-reactive protein;Total opioid use;Incidence of complications;Postoperative nausea and vomiting;Sleep disruption caused by pain;Adrenaline;Cortisol;Norepinephrine;	—

Countries

China

Contacts

Public ContactGuo Mingling

The First Affiliated Hospital of Gan'nan Medical College

744538470@qq.com+86 15770740276

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026